Quimica Sintetica Sa, based in Spain, is a pharmaceutical company.
One of their notable products is RABEPRAZOLE SODIUM (PROCESS II), with a corresponding US DMF Number 25309.
Remarkably, this DMF maintains an Active status since its submission on September 20, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 06, 2014, and payment made on February 14, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II